SEC Form 4 · accession 0001019687-15-004262
Medytox Solutions, Inc. · MMMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Benjamin Frank
Director
Period of report
Nov 2, 2015
Accepted (ET)
Nov 20, 2015 · 11:47 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374536
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Common StockF1 | $5.00 | Nov 2, 2015 | D | 100,000 | A | Apr 19, 2013 | Apr 19, 2017 | Common Stock | 100,000 | 0 | D |
| Options to Purchase Common StockF1 | $5.00 | Nov 2, 2015 | D | 50,000 | A | Apr 19, 2014 | Apr 19, 2017 | Common Stock | 50,000 | 0 | D |
| Options to Purchase Common StockF2 | $2.50 | Nov 2, 2015 | D | 100,000 | A | Apr 19, 2013 | Apr 19, 2017 | Common Stock | 100,000 | 0 | D |
| Options to Purchase Common StockF3 | $2.50 | Nov 2, 2015 | D | 50,000 | A | Apr 19, 2014 | Apr 19, 2017 | Common Stock | 50,000 | 0 | D |
Explanation of responses
- F1Cancelled pursuant to merger agreement and related transactions among Medytox Solutions, Inc. ("Medytox"), CollabRx Merger Sub, Inc. ("Merger Sub") and Rennova Health, Inc. ("Rennova") (f/k/a/ CollabRx, Inc.).
- F2Disposed of pursuant to merger agreement among Medytox, Merger Sub and Rennova. The options were assumed by Rennova in the merger and replaced with options to purchase 40,963 shares of Rennova common stock at an exercise price of $6.11 per share.
- F3Disposed of pursuant to merger agreement among Medytox, Merger Sub and Rennova. The options were assumed by Rennova in the merger and replaced with options to purchase 20,481 shares of Rennova common stock at an exercise price of $6.11 per share.